Skip to main content
. 2018 Dec 14;18(4):379–391. doi: 10.5230/jgc.2018.18.e37

Table 5. EORTC QLQ-C30.

EORTC QLQ-C30 Global health status Functioning scores Symptom scores Symptoms-single items
QL2 PF EF RF CF SF FA NV PA DI DY AP SL CO FI
1st PIPAC 52±5.9 78±4.8 69±4.8 59±6.9 87±4.7 62±7.6 33±5.2 24±7.3 25±5.0 40±9.8 21±6.0 29±8.9 29±7.4 13±5.1 11±5.1
2nd PIPAC 51±8.3 66±7.5 66±8.3 52±8.0 79±8.2 44±7.7 36±6.2 21±8.2 35±6.6 29±13 33±6.3 21±14 50±11 13±8.8 25±11
3rd PIPAC 48±14 63±13 68±8.5 47±18 73±14 47±18 22±6.1 20±12 37±14 20±13 33±18 47±17 33±0.0 7±6.7 27±6.7

Data are shown as mean±standard error of mean.

EORTC = European Organization for Research and Treatment; QLQ-C30 = quality of life questionnaire core 30; PIPAC = pressurized intraperitoneal aerosol chemotherapy; PF = physical functioning; EF = emotional functioning; RF = role functioning; CF = cognitive functioning; SF = social functioning; FA = fatigue score; NV = nausea/vomiting score; PA = pain score; DI = diarrhea score; DY = dyspnea score; AP = appetite loss score; SL = insomnia score; CO = constipation score; FI = financial difficulties.